Hennig, Stephanie and Stanning, Joseph and Staatz, Christine and Thomson, Alison (2013) Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4). pp. 289-301. ISSN 0312-5963Full text not available in this repository. (Request a copy from the Strathclyde author)
While several studies have examined the pharmacokinetics of tobramycin in patients with cystic fibrosis (CF), there is no consensus on whether they differ in patients with and without CF. The objectives of this study were to identify covariates which explain pharmacokinetic variability and to examine whether having the disease CF in itself alters these relationships and drug dose requirements.
|Keywords:||tobramycin, cystic fibrosis, pharmacokinetics, pharmacometrics, patients, Pharmacy and materia medica, Pharmacology, Pharmacology (medical)|
|Subjects:||Medicine > Pharmacy and materia medica|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences|
|Depositing user:||Pure Administrator|
|Date Deposited:||07 Dec 2012 15:55|
|Last modified:||25 Nov 2016 03:33|